As clinical supply managers, we are not here for the times when things are going well. We are here because change happens and things go wrong that impact the supply chain. We need to be able to see when change is coming and manage through that change.
Main profile
Associate Director, Janssen Pharmaceuticals, Inc., Companies of Johnson & Johnson
Buz Hillman has worked in supply chain management in the healthcare sector for more than 30 years. At Janssen Pharmaceuticals, he is responsible for developing, leading and managing strategic improvement initiatives in key clinical supply processes through enhancement of cross-functional and individual processes, IT systems, and supporting tools across all functions. Buz has focused on innovative approaches to clinical supply forecasting and IWR data analysis, resulting in significant changes in the way clinical supplies are managed within the corporation. His efforts have been recognized with several prestigious innovation awards over the past 5 years.
LEARN MORE OR SPEAK WITH OUR EXPERTS
CONTACT USLeader in Clinical Trial
Management Solutions
Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.
Quick Links:
Language:
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
Innovation Theater @DrugInfoAssn #DIA2017 Kicking off at 1. Perspectives on risk-based monitoring and TQM. https://t.co/mH6Npg0kD4
RT @Xtalks: How Improving Site Payments Can Make You the Sponsor/CRO of Choice
Tune in for this live webinar with @bioclinica
https://t.co/…
Latest Blogs:
